Skip to content
Search

Latest Stories

UK seizes £10m fake ED pills as India becomes main exporter

THE British officials have seized 3.5 million fake erectile dysfunction (ED) pills worth over £10 million in 2019.

According to the Medicines and Healthcare products Regulatory Agency (MHRA), the vast majority of unlicensed ED pills had been exported from India (96 per cent).


MHRA said on Wednesday (4) that India was followed by its neighbour China (1.5 per cent) and other nations accounting for less than once per cent.

Erectile problems in general affect up to 21 per cent of men in the UK, which is equivalent to 4.3 million men in the UK. Despite this, it has been found that 44 per cent of men with ED aged 40 and over have not sought medical help and may be buying fake products online.

MHRA said in a statement: “Fake ED drugs can lead to more than just a let-down in the bedroom. There is no way of knowing what is in them nor the negative health effects they can have. While it might seem appealing to skip the need for an assessment from a healthcare professional by buying medicines online, men with erectile problems may be putting their health at risk.

“Fake medicines may not contain any active ingredients, or worse, may contain toxic ingredients which could lead to serious health consequences.”

The MHRA’s enforcement team has worked with UK Border Force to seize millions of unlicensed medicines at the border.

Often illegal traders pose as legitimate suppliers, selling medications that are unlicensed for the UK market and offering tempting prices lower than the real deal.

Since the launch of the #FakeMeds campaign in 2016, the MHRA has been continuing to crack down by closing illegally operating sites selling unlicensed products.

More than half of all medicines and medical devices bought online are fake or counterfeit, highlighting the need for enforcement activity and public awareness to protect and improve the UK’s public health.

With this new phase of #FakeMeds, the agency is using the campaign to encourage people who buy medication online to make sure they are purchasing from safe and legitimate sources.

It also encourages people to report suspected dodgy ED drugs, and any side effects experienced to the Yellow Card scheme.

The #FakeMeds campaign is a public health campaign which aims to reduce the harm caused by purchasing fake, unlicensed or counterfeit medical products online.

More For You

Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less
India-US trade talks collapse over tariff disputes

FILE PHOTO: US president Donald Trump and Indian prime minister Narendra Modi shake hands as they attend a joint press conference at the White House in Washington, D.C., U.S., February 13, 2025. REUTERS/Kevin Lamarque.

India-US trade talks collapse over tariff disputes

TRADE talks between India and the US have hit a roadblock over disagreements on import duties for auto components, steel and farm goods, Indian officials with direct knowledge said, dashing hopes of reaching a deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

The deadlock marks a sharp shift from earlier optimism, following Trump's claim that New Delhi had proposed a "no tariffs" agreement for American goods, and officials from both sides suggesting India could be among the first countries to strike a deal on the new US tariffs.

Keep ReadingShow less